Ionis Pharmaceuticals Inc.

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ionis Pharmaceuticals

Insiders Updates

Ionis Pharmaceuticals Inc’s recent filing unveils that its EVP CLO & General Counsel O’NEIL PATRICK R. unloaded Company’s shares for

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Ionis Pharmaceuticals Inc’s recently made public that its EVP CLO & General Counsel O’NEIL PATRICK R. unloaded Company’s shares for

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ionis Pharmaceuticals

Insiders Updates

Ionis Pharmaceuticals Inc’s filing revealed that its EVP CLO & General Counsel O’NEIL PATRICK R. unloaded Company’s shares for reported

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Ionis Pharmaceuticals Inc’s filing revealed that its EVP CLO & General Counsel O’NEIL PATRICK R. unloaded Company’s shares for reported

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ionis Pharmaceuticals

Analysts Viewpoint

In a filing, Ionis Pharmaceuticals Inc revealed its Officer Schneider Eugene acquired Company’s shares for reported $56100.0 on Jan 31

Tag: Ionis Pharmaceuticals Inc.